Paxlovid Rebound: Proposed Strategy to Prevent Reinfection Following Treatment of COVID-19 Positive Nonhospitalized Patients
Main Article Content
Keywords
COVID-19; SARS-CoV-2; BA.5; Omicron; Paxlovid; CDC: Centers for Disease Control and Prevention; FDA: U.S. Food and Drug Administration; WHO: World Health Organization
Abstract
NA